APEX Global Solutions Limited's IPO may not be a wise investment amid growth concerns, high risk, and steep valuation. Click ...
New guidelines on NHS management of type 2 diabetes will introduce a more personalised approach that could see expanded access to drug treatments, including GLP-1 agonist therapies. The shift from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback